SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments. 

Venture Capital

Therapeutics

Life Sciences

Health Care

Biotechnology

SymBiosis

Chidozie Ugwumba

Allie Ivy

Catherine Shoults

Aleksei Cremo

SymBiosis

Org chart

Similar companies